Syra Health Announces the Launch of Syrenity, an AI-backed Mental Health Product for Organizations Offering Mental Health Workforce Solutions
CARMEL, IN, October 24, 2023 /PRNewswire/— Syra Health Corp. (NASDAQ: SYRA) (“Syra Health” or the “Company”), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today the launch of Syrenity, a mental health product that proactively identifies the negative factors impacting mental health and integrates telehealth for mental health treatment and services.
Syrenity encompasses a range of features aimed at continual monitoring, cognitive therapy interventions, and convenient access to licensed therapists via telehealth. Its user-centric design ensures an intuitive experience for individuals from all backgrounds. The unique advantage of Syrenity is its evidence-based approach, utilizing scientifically proven methods and techniques to assess and address behavioral and mental health concerns. Through a series of assessments, Syrenity will create a personalized profile for each user, which will serve as a starting point for developing targeted activities, education, and interventions.
“We are proud to introduce Syrenity, a comprehensive tool that empowers anyone to proactively take control of their mental health," said Sandeep Allam, Executive Chairman and President, Syra Health. "In today's world, prioritizing mental well-being is more important than ever, and Syrenity provides a holistic and accessible solution."
Syrenity is designed to address the large yet underserved population confronting mental health issues. According to the National Alliance on Mental Illness or NAMI, one in five adults living in the U.S. experiences mental illness annually, while one in 20 experiences serious mental illness each year.
“Syrenity includes an AI-backed diary that engages the user in a conversation and the ability to assess behavioral health needs,” said Dr. Srikant Devaraj, Vice President of Health Analytics, Syra Health. “Syrenity also provides easy-to-access user reports for therapists to deliver effective care.”
By offering convenient and secure access to professional care, Syrenity contributes to an improved quality of life for its users. To learn more about Syrenity or schedule a demo, please visit our website at www.syrahealth.com.
ABOUT SYRA HEALTH CORP.
Syra Health is a healthcare company with a mission to improve healthcare by providing innovative services and technology solutions. Syra Health aims to achieve its goal by becoming a valuable partner to government, payers, providers, life sciences organizations, and academic institutions. Syra Health offers products and services in digital health, behavioral and mental health, population health management, health education, and healthcare workforce. For more information, please visit www.syrahealth.com.
SAFE HARBOR STATEMENT
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds,
the Company’s operations and business strategy and the Company’s expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors discussed in the "Risk Factors" section of the prospectus filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For more information, please contact:
For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health Corp.
463-345-5180
For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
